Safety Alerts & Recalls
The Food and Drug Administration (FDA) has issued warning letters to five distributors of pure powdered caffeine due to its danger and significant risk of illness or injury to consumers.
The Food and Drug Administration (FDA) is warning that use of dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain which could be severe and disabling.
Novacare announced a voluntary recall of dietary supplements marketed as an aid to weight loss due to undeclared salicylic acid.
Allergan plc. announced a voluntary recall of specific lots of REFRESH Lacri-Lube, REFRESH PM, FML (fluorometholone ophthalmic ointment) 0.1%, and Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment USP) 10%/0.2% due to the presence of particular matter.
The Food and Drug Administration (FDA) is warning about reports of severe allergic reactions and herpes zoster associated with the use of Picato (ingenol mebutate topical gel).
Merck announced a voluntary recall of Temodar (temozolomide) and its generic Temozolomide (Sandoz) capsules due to the potential for the bottle caps to be cracked.
Boehringer Ingelheim announced a voluntary recall of over 350,000 Combivent Respimat (ipratropium bromide, albuterol) inhalation sprays due to a defective delivery system.
The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xenical (orlistat; Genentech) regarding new drug interactions and adverse reaction updates to its labeling.
Blue Square Market, Inc. announced voluntary recalls of Kaboom Action Strips and LiDa DaiDaiHua due to the presence of undeclared active ingredients.
The Food and Drug Administration (FDA) is warning consumers not to buy or use Achieving Zero, a supplement marketed for weight loss.
- New CDC Recommendations for Influenza Vaccination: 2015-2016
- First Reported Case of Myopericarditis With Common BP Med
- Many Pregnant Women Lacking in Element Linked to Cognition in Offspring
- Severe, Persistent Joint Pain Warning Issued for Diabetes Drug Class
- New Insight into Antibiotics-Type 2 Diabetes Link